Researchers Use Puppets To Teach Toddlers
CINCINNATIUC environmental health researchers will use 15-foot-tall puppets to educate nearly 500 young children and their families about air pollution at the 5th Annual Cincinnati Childhood Allergy and Air Pollution Study (CCAAPS) family picnic.
The event takes place Saturday, Oct. 7, at the Cincinnati Zoo and Botanical Gardens Wings of Wonder Amphitheater from 11:00 a.m. to 1:00 p.m. The puppet show, which begins at 11:30 a.m., has been developed in conjunction with puppeteers from ImagineNation, who, in addition to performing the educational program titled Gloomy Doomy, Go Away! have custom designed puppets and settings for the event.
The families are participants in an epidemiologic study, funded by the National Institute of Environmental Health Sciences (NIEHS), that is examining the effects of diesel exhaust on childhood respiratory health and allergy development in an effort to better understand and develop ways to combat early childhood allergies.
Grace LeMasters, PhD, an epidemiologist and principal investigator for CCAAPS, will explain the UC research teams recent findings and offer practical advice on how to minimize childrens exposure to negative environmental factors. For example:
- Discourage idling of school buses to decrease childrens exposure to diesel exhaust, which has been related to wheezing
- Remove, with a dilution of bleach water, visible mold and water damage in the home, which is also associated with wheezing
Most recently the team found that infants born to parents with allergies are much more susceptible to develop allergies by ages 1 and 2 than previously thought.
All participants will receive free admission to the Cincinnati Zoo, lunch and prizes. The event is sponsored by NIEHS, the Ohio Environmental Protection Agency, AstraZeneca and Sepracor.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.